Centre for Clinical & Basic Research, IRCCS San Raffaele Pisana, via della Pisana, 235, 00163, Rome, Italy.
Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
ESC Heart Fail. 2022 Oct;9(5):2767-2778. doi: 10.1002/ehf2.14076. Epub 2022 Jul 22.
Heart failure (HF) is a long-term clinical syndrome, with increasing prevalence and considerable healthcare costs that are further expected to increase dramatically. Despite significant advances in therapy and prevention, mortality and morbidity remain high and quality of life poor. Epidemiological data, that is, prevalence, incidence, mortality, and morbidity, show geographical variations across the European countries, depending on differences in aetiology, clinical characteristics, and treatment. However, data on the prevalence of the disease are scarce, as are those on quality of life. For these reasons, the ESC-HFA has developed a position paper to comprehensively assess our understanding of the burden of HF in Europe, in order to guide future policies for this syndrome. This manuscript will discuss the available epidemiological data on HF prevalence, outcomes, and human costs-in terms of quality of life-in European countries.
心力衰竭（HF）是一种长期的临床综合征，其患病率不断增加，医疗保健费用也相当高，预计还会大幅增加。尽管在治疗和预防方面取得了重大进展，但死亡率和发病率仍然很高，生活质量也很差。流行病学数据（即患病率、发病率、死亡率和发病率）显示，欧洲各国之间存在地域差异，这取决于病因、临床特征和治疗的差异。然而，关于疾病流行率的数据稀缺，生活质量数据也是如此。出于这些原因，ESC-HFA 制定了一份立场文件，全面评估我们对欧洲 HF 负担的理解，以便为该综合征的未来政策提供指导。本文将讨论欧洲国家 HF 患病率、结局和人力成本（即生活质量）方面的现有流行病学数据。
